Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IOVA
IOVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IOVA News
Iovance Biotherapeutics Files Registration Statement for sec
2d ago
Yahoo Finance
GT Biopharma Advances Three Drug Candidates into Clinical Trials
Jun 08 2026
Globenewswire
GT Biopharma Advances Three Cancer Drug Candidates into Clinical Trials
Jun 08 2026
Newsfilter
Iovance Biotherapeutics Secures Conditional Approval for Amtagvi in Australia
Jun 04 2026
seekingalpha
Iovance Biotherapeutics Stock Volatility Analysis
Jun 02 2026
Fool
Iovance Biotherapeutics Stock Volatility and Growth Prospects
Jun 02 2026
NASDAQ.COM
Biotech Companies Focus on Drug Delivery Technologies
Jun 01 2026
Globenewswire
Biotech Companies Focus on Drug Delivery Technologies
Jun 01 2026
Newsfilter
Iovance Expands Tumor Treatment Platform with FDA Approval
Jun 01 2026
Newsfilter
Iovance Grants Stock Options to New Employees
May 22 2026
Newsfilter
Iovance Reports Wider Than Expected Q1 Loss Amid Approval Delays
May 07 2026
stocktwits
Iovance Biotherapeutics Misses Q1 Expectations, Shares Drop
May 07 2026
seekingalpha
Iovance Biotherapeutics Q1 Earnings Analysis
May 07 2026
seekingalpha
Iovance Biotherapeutics Set to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Iovance Biotherapeutics Stock Performance Analysis
May 02 2026
Fool
IOVA Benefits from Rival Drug Rejection, Analysts Bullish
Apr 10 2026
stocktwits
Show More News
